Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 32

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 32
---
 ] shares of Common Stock actually issued and
outstanding as of May 29, 2025. The table does not account for fractional shares that will be paid in cash.

|                                                                                                                                                                                                                                  |     | Estimated      
 Number of      
 Shares of      
 Common Stock   
 Before Reverse 
 Stock Split    |             |     | Estimated        
 Number of        
 Shares of        
 Common Stock     
 After Reverse    
 Stock Split on a 
 1-for-10 basis   |             |     | Estimated        
 Number of        
 Shares of        
 Common Stock     
 After Reverse    
 Stock Split on a 
 1-for-25 basis   |             |
| Authorized Common Stock as of the Record Date                                                                                                                                                                                    |     |                | 100,000,000 |     |                  | 100,000,000 |     |                  | 100,000,000 |
| Shares of Common Stock issued and outstanding                                                                                                                                                                                    |     |                |             |     |                  |             |     |                  |             |
| Shares of Common Stock issuable under outstanding options, warrants or reserved for issuance under existing plans                                                                                                                |     |                |             |     |                  |             |     |                  |             |
| Shares of Common Stock authorized but unissued (Authorized Common Stock minus issued and outstanding shares, shares issuable upon outstanding options, warrants and shares reserved for issuance under existing incentive plans) |     |                |             |     |                  |             |     |                  |             |
| Shares of Common Stock authorized but unissued (Authorized Common Stock assuming that the Authorized                                                                                                                             
 Increase Proposal is approved and the authorized increase is effected minus issued and outstanding shares, shares issuable upon outstanding                                                                                      
 options, warrants and shares reserved for issuance under existing incentive plans)                                                                                                                                               |     |                |             |     |                  |             |     |                  |             |

We are currently authorized to issue
a maximum of 100,000,000 shares of our Common Stock. If Proposal 5 is approved and the authorized increase is effected, the authorized
number of shares of Common Stock will be increased to 350,000,000. As of the Record Date, there were [ ] shares of our Common
Stock issued and outstanding. Although the number of authorized shares of our Common Stock will not change as a result of the Reverse
Stock Split, the number of shares of our Common Stock issued and outstanding will be reduced in proportion to the ratio selected by the
Board. Thus, the Reverse Stock Split will effectively increase the number of authorized and unissued shares